FDA Reverses Decision, Allowing Amicus To File For Rare Disease Drug

Last November, tiny Amicus Therapeutics said that the Food and Drug Administration would not consider approving migalastat, a treatment for a rare disorder called Fabry disease. Today, Amicus says that the FDA is reversing the decision, and that there is a clear path to approval.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NASDAQ:FOLD Source Type: news